Login / Signup

Efficacy and safety of degludec U100 versus glargine U300 for the early postoperative management of patients with type 2 diabetes mellitus undergoing coronary artery bypass graft surgery: A non-inferiority randomized trial.

Mohammad Shafi KuchayAnu MathewMitali MishraParvathi SurendranParjeet KaurJasjeet Singh WasirHarmandeep Kaur GillRujul JainSakshi GagnejaChhavi KohliPoonam KumariManish Kumar SinghSunil Kumar Mishra
Published in: Diabetic medicine : a journal of the British Diabetic Association (2022)
Treatment with degludec U100 is as effective and safe as glargine U300 for the early postoperative hospital management of patients with T2D undergoing CABG.
Keyphrases
  • coronary artery bypass
  • percutaneous coronary intervention
  • patients undergoing
  • healthcare
  • glycemic control
  • acute coronary syndrome
  • emergency department
  • acute care
  • atrial fibrillation
  • drug induced